Article info
PDFCommentaries
Improving drug delivery to pancreatic cancer: breaching the stromal fortress by targeting hyaluronic acid
- Correspondence to Professor Thomas M Gress, Department of Gastroenterology, Endocrinology, Metabolism and Infectiology, University of Marburg, Baldinger Strasse, D-35043 Marburg, Germany; thomas.gress{at}med.uni-marburg.de
Citation
Improving drug delivery to pancreatic cancer: breaching the stromal fortress by targeting hyaluronic acid
Publication history
- First published June 3, 2012.
Online issue publication
April 18, 2016
Article Versions
- Previous version (18 April 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© 2012, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.